What is the appropriate diagnostic workup for a smoker with chronic diarrhea who presents with mediastinal lymphadenopathy?

Diagnostic Workup for Mediastinal Lymphadenopathy in a Smoker with Chronic Diarrhea

This patient requires immediate tissue diagnosis via endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA) of the mediastinal lymph nodes, with concurrent workup of the chronic diarrhea including colonoscopy with biopsies, coeliac serology, and faecal calprotectin.

Prioritized Diagnostic Approach

Mediastinal Lymphadenopathy Workup

The combination of smoking history and mediastinal lymphadenopathy raises immediate concern for lung cancer with nodal involvement, lymphoma, or granulomatous disease (sarcoidosis, tuberculosis). The presence of chronic diarrhea creates diagnostic complexity that requires parallel investigation.

Primary tissue diagnosis strategy:

• EBUS-TBNA is the cornerstone diagnostic modality for mediastinal lymphadenopathy 1. This minimally invasive technique provides both cytological and histological material when performed with appropriate sampling techniques 2, 3.

• The diagnostic accuracy of EBUS-TBNA reaches 91% with a negative predictive value of 84.2% in isolated mediastinal/hilar lymphadenopathy 4. However, in carefully selected low-risk patients (younger age, relevant comorbidity absent, lymph nodes <20mm), the NPV increases to 93.8% 4.

• Rapid on-site evaluation (ROSE) during EBUS-TBNA is critical to ensure adequate sampling and appropriate triage of specimens for immunohistochemistry, immunophenotyping, and molecular studies 3. This is particularly important for distinguishing lymphoma subtypes and obtaining tissue for molecular profiling in lung cancer.

• If EBUS-TBNA yields insufficient tissue, supplemental EBUS-guided forceps biopsy increases diagnostic sensitivity from 50% to 82%, especially when biopsy specimens measure ≥3mm 2.

Imaging Strategy

Contrast-enhanced CT chest is the initial imaging modality for characterizing mediastinal masses and lymphadenopathy 5.

• FDG-PET/CT should be obtained if lymphoma is suspected or for staging confirmed lung cancer, as it has become standard for lymphoma staging and assessment 5. However, recognize that positive FDG-PET/CT has limited specificity in the prevascular mediastinum due to normal thymic uptake 5.

• MRI chest provides superior tissue characterization but is typically reserved for indeterminate masses after CT evaluation 5.

Chronic Diarrhea Workup in This Context

The chronic diarrhea must be investigated in parallel, as it may represent:

1. Paraneoplastic syndrome from lung cancer or lymphoma
2. Hormone-secreting tumor (though rare, testing should occur only after excluding common causes) 6
3. Concurrent gastrointestinal pathology requiring independent evaluation

Initial non-invasive investigations per British Society of Gastroenterology guidelines:

• Coeliac serology, faecal calprotectin, and faecal immunochemical testing (FIT) should be completed initially 6
• Colonoscopy with biopsies of right and left colon is mandatory given the patient's smoking history (age likely >40) and need to exclude colorectal malignancy 6. All patients undergoing colonoscopy for chronic diarrhea require histological examination of biopsies 6.

Critical Clinical Decision Points

Age and smoking status drive urgency:

• In patients >40 years with smoking history, the threshold for invasive investigation is appropriately low given the clinical significance of lung cancer and lymphoma 6.
• Do not delay tissue diagnosis with prolonged non-invasive workup when malignancy is suspected.

If EBUS-TBNA is negative:

• In high-risk patients (older age, larger lymph nodes >20mm, no relevant comorbidity explaining reactive nodes), proceed to mediastinoscopy rather than surveillance 4.
• In low-risk patients with negative EBUS-TBNA, short-interval surveillance imaging at 3-6 months may be appropriate 5, 4.

Common Pitfalls to Avoid

• Do not attribute mediastinal lymphadenopathy to sarcoidosis without tissue confirmation, especially in a smoker where lung cancer is more likely.
• Do not perform extensive diarrhea workup for rare causes (hormone-secreting tumors) before establishing the diagnosis of the mediastinal process 6.
• Do not rely on cytology alone from EBUS-TBNA—ensure cell block preparation and adequate tissue for ancillary studies, particularly for lymphoma diagnosis 3.
• Do not miss the opportunity for molecular testing in lung cancer by obtaining insufficient tissue at initial sampling.

Integration of Findings

Once tissue diagnosis is established from mediastinal lymph nodes:

• If lung cancer: The chronic diarrhea may represent paraneoplastic syndrome or metastatic disease requiring staging PET/CT
• If lymphoma: Gastrointestinal involvement should be assessed as part of staging
• If granulomatous disease: Consider gastrointestinal tuberculosis or Crohn's disease as potential causes of both findings
• If benign/reactive nodes: Complete the full chronic diarrhea algorithm per BSG guidelines, including bile acid diarrhea testing if initial workup is unrevealing 6